Bringing New Solutions to Chronic Kidney Disease

The Renal Health Program of the Center for Translational Medicine and Pharmacology Research strives to apply new molecular tools to understand, prevent, and treat kidney disease. The group, under the leadership of Ilse Daehn, PhD, takes a multidisciplinary approach with the goal of identifying key biomarkers and therapeutic targets, in tandem with examining the genetics risk for developing diabetic kidney disease.

Chronic kidney disease is estimated to affect more than 13 percent of American adults and is on the rise. More than 76 percent of these cases are caused by glomerular diseases with progressive glomerulosclerosis lesions, including diabetic nephropathy (37 percent), hypertensive nephropathy (24 percent), and glomerulonephritis (15 percent). The Renal Health Program is studying each of these potential causes for clues to prevent and treat renal disease.

Current Research

The Renal Health Program is involved with two major research projects.

Exploring Signaling Crosstalk Among Cells in the Kidney

The Renal Health Program identified an unexpected cellular cross-talk among cells in the glomerulus, thus revealing a previously unrecognized interdependence of cells in the kidney glomerulus. In particular, the researchers are examining the signaling crosstalk among podocytes, endocapillary cells, and mesangial cells. The findings from these efforts have laid a path for exploring the early reversible phase of the disease, and this study provides an unprecedented opportunity to discover novel glomerular lesion-specific therapeutic targets of kidney disease and its progression.

Genetic Susceptibility to Developing Progressive Kidney Disease

Using knowledge gained from animal studies, the group is seeking to identify biomarkers in urine for early detection of disease and its progression. This research effort has so far led to the discovery of DNA variants linked to the regulation of xanthine oxidoreductase and production of reactive-oxygen species in relation to the susceptibility to diabetic kidney complications and aging. Early detection of patients at risk would improve chances for successful management and/or treatment through precision medicine.

Contact Us